
Findings may lead to new treatment that protects nerves from damage caused in optic neuritis and throughout the central nervous system during MS attacks.

Findings may lead to new treatment that protects nerves from damage caused in optic neuritis and throughout the central nervous system during MS attacks.

David D'Altorio, PharmD, senior vice president of health services at MedImpact Healthcare Systems, discusses how specialty pharmacies can enhance their operations with data analytics.

Newly identified biomarker may help determine whether patients will need chemotherapy post-surgery.

Cutaneous psoriasis used to describe an individual who suffered from the disease for at least a decade.

Adcetris is currently the only approved molecular-targeted therapy for Hodgkins lymphoma.

Top news of the week in cancer drug development and research.

Serum antibody repertoires may serve as biomarkers for the pathology and progression of multiple sclerosis.

Study is the first to show a decrease in migraine frequency from medical marijuana.

Catch up with the latest developments across the health care landscape and sign up for key upcoming conferences and continuing education activities.

Catch up with the top news of the week from The American Journal of Pharmacy Benefits.

Zepatier is a once-daily, fixed-dose combination containing with the NS5A inhibitor elbasvir and the NS3/4A protease inhibitor grazoprevir.

Halaven treats liposarcoma patients who received prior chemotherapy that contained an anthracycline drug.

Lynparza is a first in class PARP inhibitor for the monotherapy treatment of patients with metastatic castration resistant prostate cancer.

Venetoclax is an inhibitor of the B-cell lymphoma-2 protein used in combination with hypomethylating agents in treatment-naive AML patients.

Novo Nordisk's insulin degludec injection is now available in pharmacies nationwide.

A host of new inhalers for chronic obstructive pulmonary disease are nearing market entry.

NFL Hall of Famer and Super Bowl champion Mike Haynes seeks to spread awareness about prostate cancer following his fight with the disease.

Researchers seek to predict age-related responses to hepatitis B vaccination.

Handheld miniature microscope allows surgeons to see cancer at a cellular level.

Younger melanoma patients undergo indoor tanning more frequently than older women with melanoma.

Few MS patients are treated for depression through psychotherapy or pharmaceutical therapy.

Health officials in Arizona successfully created a campaign last year that raised HIV awareness and led many more residents to visit the state's resource page for HIV education, testing, and services.

Study finds passage of Affordable Care Act caused a spike in ER visits for young adults with mental illnesses and circulatory system disease.

Abraxane and gemcitabine evaluated in first-line patients with metastatic pancreatic cancer.

Centers for Medicare and Medicaid Services issues final ruling that seeks to rein in the growing cost of prescription drugs.

Inherited genetic markers in immune response pathways associated with melanoma survival.

Sirolimus shows promise in decreasing skin cancer risk among organ transplant patients.

Iron accumulation may precede more pronounced brain atrophy.

The expanded use of Opdivo and Yervoy includes patients with BRAF V600 wild-type mutation-positive unresectable or metastatic melanoma.